MAM
Morse Asset Management Portfolio holdings
AUM
$456M
This Quarter Return
+13.91%
1 Year Return
+29.91%
3 Year Return
+155.16%
5 Year Return
+306.41%
10 Year Return
–
AUM
$340M
AUM Growth
+$340M
(+7.5%)
Cap. Flow
-$14.2M
Cap. Flow
% of AUM
-4.18%
Top 10 Holdings %
Top 10 Hldgs %
31.85%
Holding
141
New
11
Increased
42
Reduced
63
Closed
15
Top Buys
| 1 |
Ares Management
ARES
|
$1.47M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
$1.38M |
| 3 |
Apollo Global Management Series A
APO.PRA
|
$1.22M |
| 4 |
Emcor
EME
|
$1.15M |
| 5 |
Boeing
BA
|
$1.15M |
Top Sells
| 1 |
ON Semiconductor
ON
|
$3.47M |
| 2 |
S&P Global
SPGI
|
$1.62M |
| 3 |
Devon Energy
DVN
|
$1.56M |
| 4 |
Zoetis
ZTS
|
$1.44M |
| 5 |
Albemarle
ALB
|
$1.38M |
Sector Composition
| 1 | Technology | 30.25% |
| 2 | Healthcare | 15.26% |
| 3 | Consumer Discretionary | 12.6% |
| 4 | Industrials | 9.12% |
| 5 | Communication Services | 8.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Costco
COST
$418B
| $4.28M | 1.26% |
6,480
-545
| -8% | -$360K |
|
27
Applied Materials
AMAT
$128B
| $4M | 1.18% |
24,677
-549
| -2% | -$89K |
|
28
Regeneron Pharmaceuticals
REGN
$61.5B
| $3.99M | 1.17% |
4,537
+430
| +10% | +$378K |
|
29
Mastercard
MA
$538B
| $3.94M | 1.16% |
9,233
+259
| +3% | +$110K |
|
30
Diamondback Energy
FANG
$43.1B
| $3.94M | 1.16% |
25,380
+707
| +3% | +$110K |
|
31
Vertex Pharmaceuticals
VRTX
$100B
| $3.86M | 1.14% |
9,489
+1,547
| +19% | +$629K |
|
32
GXO Logistics
GXO
$6.03B
| $3.45M | 1.02% |
56,448
-1,345
| -2% | -$82.3K |
|
|
33
Apollo Global Management
APO
$77.9B
| $3.43M | 1.01% |
36,789
-143
| -0.4% | -$13.3K |
|
34
Intercontinental Exchange
ICE
$101B
| $3.28M | 0.96% |
25,498
-1,996
| -7% | -$256K |
|
|
35
Boeing
BA
$177B
| $3.23M | 0.95% |
12,401
+4,402
| +55% | +$1.15M |
|
36
Cintas
CTAS
$84.6B
| $3.22M | 0.95% |
5,344
+523
| +11% | +$315K |
|
37
Tesla
TSLA
$1.08T
| $3.07M | 0.9% |
12,369
+393
| +3% | +$97.6K |
|
38
NXP Semiconductors
NXPI
$59.2B
| $3.07M | 0.9% |
13,353
| – | – |
|
39
Merck
MRK
$210B
| $2.68M | 0.79% |
24,534
-7,681
| -24% | -$837K |
|
40
Freeport-McMoran
FCX
$63.7B
| $2.59M | 0.76% |
60,916
+704
| +1% | +$30K |
|
41
Onto Innovation
ONTO
$5.19B
| $2.54M | 0.75% |
16,599
-486
| -3% | -$74.3K |
|
42
Iron Mountain
IRM
$27.3B
| $2.53M | 0.75% |
36,190
| – | – |
|
43
Novo Nordisk
NVO
$251B
| $2.51M | 0.74% |
24,305
+4,295
| +21% | +$444K |
|
|
44
Apollo Global Management Series A
APO.PRA
$2.06B
| $2.51M | 0.74% |
44,625
+21,640
| +94% | +$1.22M |
|
45
Netflix
NFLX
$513B
| $2.43M | 0.71% |
4,982
-339
| -6% | -$165K |
|
46
Sherwin-Williams
SHW
$91.2B
| $2.23M | 0.66% |
7,148
-957
| -12% | -$298K |
|
47
D.R. Horton
DHI
$50.5B
| $2.22M | 0.65% |
14,610
+1,600
| +12% | +$243K |
|
48
Marathon Petroleum
MPC
$54.6B
| $2.12M | 0.62% |
14,253
+1,898
| +15% | +$282K |
|
49
Intel
INTC
$107B
| $2.07M | 0.61% |
41,258
-7,979
| -16% | -$401K |
|
50
Lam Research
LRCX
$127B
| $1.9M | 0.56% |
2,429
-26
| -1% | -$20.4K |
|